Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425575 · ClinicalTrials.gov registry record
Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy
A clinical trial of Chronic Pelvic Pain Syndrome, sponsored by Thomas Jefferson University.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06425575: Active study of Chronic Pelvic Pain Syndrome, sponsored by Thomas Jefferson University.
NCT06425575 is a study of Chronic Pelvic Pain Syndrome that is active but no longer recruiting, run by Thomas Jefferson University. The registered enrollment target is 50 participants, below the 192-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06425575, a study of Chronic Pelvic Pain Syndrome, is active but no longer recruiting, sponsored by Thomas Jefferson University.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This goal of this study is to determine whether a novel biologic, i.e., an "amniotic suspension allograft" (ASA) will reduce pain and improve quality of life (QoL) in women stricken with chronic pelvic pain (CPP). The main questions it aims to answer are: * Weather pain in the genitalia is reduced with treatment * Weather bladder or urination pain is reduced with treatment * Weather any adverse events occur following treatment Patient responses to pain and QoL will be collected before and 6-12 months after treatment.
Conditions Studied
Interventions
- BIOLOGICAL Amniotic suspension allograft
Study Locations (1)
Pennsylvania
- Thomas Jefferwson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2024-07-01 |
What the registry record for NCT06425575 still lists
NCT06425575 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 192-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Chronic Pelvic Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Amniotic suspension allograft is the first listed.
NCT06425575 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06425575 about?
NCT06425575 is a clinical study titled "Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy". This goal of this study is to determine whether a novel biologic, i.e., an "amniotic suspension allograft" (ASA) will reduce pain and improve quality of life (QoL) in women stricken with chronic pelvic pain (CPP). The main questions it aims to answer are: * Weather pain in the genitalia is reduced ...
What is the current status of trial NCT06425575?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2019-04-01. Estimated completion is 2024-07-01.
What conditions does trial NCT06425575 study?
This clinical trial studies the following conditions: Chronic Pelvic Pain Syndrome.
What interventions are being tested in trial NCT06425575?
The interventions under investigation include: Amniotic suspension allograft (BIOLOGICAL).
Who is sponsoring clinical trial NCT06425575?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06425575 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pelvic Pain Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06425575's enrollment target sits among peer trials
50 7th of 11 higher than 5 of 11 other Chronic Pelvic Pain Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pelvic Pain Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain
RECRUITING · NA
-
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions
RECRUITING
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Vaginal Baclofen Suppositories in Chronic Pelvic Pain
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI